Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphisms in genes of the de novo lipogenesis pathway and overall survival of hepatocellular carcinoma patients undergoing transarterial chemoembolization.

Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2015

Wu You-Sheng, Bao Deng-Ke, Dai Jing-Yao, Chen Cheng, Zhang Hong-Xin, Yang YeFa, Xing Jin-Liang, Huang Xiao-Jun, Wan Shao-Gui

Abstract excerpt

Aberrant expression of genes in de novo lipogenesis (DNL) pathway were associated with various cancers, including hepatocellular carcinoma (HCC). Single nucleotide polymorphisms (SNPs) of DNL genes have been reported to be associated with prognosis of some malignancies. However, the effects of SNPs in DNL genes on overall survival of HCC patients receiving transarterial chemoembolization (TACE) treatment are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetyl-CoA Carboxylase
Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Hepatocellular

Share to Follow-Up Studies

Share to Lipogenesis

Share to Liver Neoplasms

Share to Neoplasm Staging

Share to Survival Rate

Source

Identifiers

PMID: 25735330
DOI: 10.7314/apjcp.2015.16.3.1051

Genes

AFP
ACACA
ACLY
FASN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Polymorphisms in genes of the de novo lipogenesis pathway and overall survival of hepatocellular carcinoma patients undergoing transarterial chemoembolization.PMID 25735330Read ↗

Genetic variants in de novo lipogenic pathway genes predict the prognosis of surgically-treated hepatocellular carcinoma.Semantic proximity Read ↗

Fatty acid synthesis pathway genetic variants and clinical outcome of non-small cell lung cancer patients after surgery.Semantic proximity Read ↗

Identification and integrative analysis of ACLY and related gene panels associated with immune microenvironment reveal prognostic significance in hepatocellular carcinomaSemantic proximity Read ↗

Efficacy of doxorubicin and lipiodol therapy by trans-arterial chemoembolization in hepatocellular carcinoma Egyptian patients and relation to genetic polymorphisms.Semantic proximity Read ↗

The role of ACLY in regulating lipid metabolism on the occurrence and development of gastric cancerSemantic proximity Read ↗

The diplotype Fas -1377A/-670G as a genetic marker to predict a lower risk of breast cancer in Chinese women.Semantic proximity Read ↗

Genetic variations in IDH gene as prognosis predictors in TACE-treated hepatocellular carcinoma patients.Semantic proximity Read ↗

Impact of NOTCH1 polymorphisms on liver cancer in a Chinese Han population.Semantic proximity Read ↗

Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population.Semantic proximity Read ↗

Genetic Variants in ASCT2 Gene are Associated with the Prognosis of Transarterial Chemoembolisation-Treated Early- Stage Hepatocelluar Carcinoma.Semantic proximity Read ↗

Genetic variants in the KDR gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.